Literature DB >> 23152549

Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract.

Adrian J Brink1, Jennifer Coetzee, Craig Corcoran, Cornelis G Clay, Danusha Hari-Makkan, Rachael K Jacobson, Guy A Richards, Charles Feldman, Louise Nutt, Johan van Greune, J D Deetlefs, Karin Swart, Lesley Devenish, Laurent Poirel, Patrice Nordmann.   

Abstract

This study reports on the emergence of OXA-48-like carbapenemases among isolates of Enterobacteriaceae in South Africa. In addition, the emergence during therapy of a colistin-resistant OXA-181-producing Klebsiella pneumoniae isolate was documented following selective digestive tract decontamination with oral colistin, which is therefore strongly discouraged.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23152549      PMCID： PMC3536210          DOI： 10.1128/JCM.02234-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa.

Authors:  Adrian J Brink; Jennifer Coetzee; Cornelis G Clay; Sindi Sithole; Guy A Richards; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

3.  Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae.

Authors:  Georgios Meletis; Egki Tzampaz; Effrosyni Sianou; Ioannis Tzavaras; Danai Sofianou
Journal:  J Antimicrob Chemother       Date:  2011-01-25       Impact factor: 5.790

Review 4.  Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.

Authors:  Matthew E Falagas; Drosos E Karageorgopoulos; Patrice Nordmann
Journal:  Future Microbiol       Date:  2011-06       Impact factor: 3.165

5.  Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.

Authors:  Dror Marchaim; Teena Chopra; Jason M Pogue; Federico Perez; Andrea M Hujer; Susan Rudin; Andrea Endimiani; Shiri Navon-Venezia; Jatinder Hothi; Jessica Slim; Christopher Blunden; Maryann Shango; Paul R Lephart; Hossein Salimnia; Deborah Reid; Judy Moshos; Wasif Hafeez; Suchitha Bheemreddy; Ting-Yi Chen; Sorabh Dhar; Robert A Bonomo; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

6.  Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors:  S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

7.  Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands.

Authors:  Jayant S Kalpoe; Nashwan Al Naiemi; Laurent Poirel; Patrice Nordmann
Journal:  J Med Microbiol       Date:  2011-01-20       Impact factor: 2.472

8.  Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.

Authors:  Pattarachai Kiratisin; Anucha Apisarnthanarak; Chaitat Laesripa; Piyawan Saifon
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

9.  Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

Authors:  D Plachouras; M Karvanen; L E Friberg; E Papadomichelakis; A Antoniadou; I Tsangaris; I Karaiskos; G Poulakou; F Kontopidou; A Armaganidis; O Cars; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

Review 10.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883
View more
  38 in total

Review 1.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  [Colistin : renaissance of an old antibiotic?].

Authors:  H Stocker; W V Kern
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

3.  First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing.

Authors:  Yanbin Liu; Yu Feng; Wenjing Wu; Yi Xie; Xiaohui Wang; Xiaoxia Zhang; Xinchuan Chen; Zhiyong Zong
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

Review 4.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

5.  Identification of the OXA-48 Carbapenemase Family by Use of Tryptic Peptides and Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Jeffrey R Strich; Honghui Wang; Ousmane H Cissé; Jung-Ho Youn; Steven K Drake; Yong Chen; Avi Z Rosenberg; Marjan Gucek; Patrick T McGann; John P Dekker; Anthony F Suffredini
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

6.  Inappropriate dose of enteral antimicrobials promotes resistance.

Authors:  L Silvestri; C Negri; N Taylor; D F Zandstra; H K F van Saene
Journal:  J Clin Microbiol       Date:  2013-05       Impact factor: 5.948

7.  Reply to "selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene".

Authors:  Teysir Halaby; Nashwan Al Naiemi; Christina M J E Vandenbroucke-Grauls
Journal:  Antimicrob Agents Chemother       Date:  2014-06       Impact factor: 5.191

Review 8.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

9.  Screening and Characterization of Multidrug-Resistant Gram-Negative Bacteria from a Remote African Area, São Tomé and Príncipe.

Authors:  Laurent Poirel; Marta Aires-de-Sousa; Patrick Kudyba; Nicolas Kieffer; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

Review 10.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.